New genes in inflammatory bowel disease: lessons for complex diseases? by Gaya, DR, Russell, RK, Nimmo, ER, Satsangi, J

Relapse after withdrawal from anti‐TNF therapy for inflammatory bowel disease: an observational study, plus systematic review and meta‐analysis by Kennedy, NA, Warner, B, Johnston, EL, Flanders, L, Hendy, P, Ding, NS, Harris, R, Fadra, AS, Basquill, C, Lamb, CA, Cameron, FL, Murray, CD, Parkes, M, Gooding, I, Ahmad, T, Gaya, DR, Mann, S, Lindsay, JO, Gordon, J, Satsangi, J, Hart, A, McCartney, S, Irving, P, Lees, CW

Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study by Kennedy, NA, Heap, GA, Green, HD, Hamilton, B, Bewshea, C, Walker, GJ, Thomas, A, Nice, R, Perry, MH, Bouri, S, Chanchlani, N, Heerasing, NM, Hendy, P, Lin, S, Gaya, DR, Cummings, JRF, Selinger, CP, Lees, CW, Hart, AL, Parkes, M, Sebastian, S, Mansfield, JC, Irving, PM, Lindsay, J, Russell, RK

Association of genetic variants in NUDT15 with thiopurine-induced myelosuppression in patients with inflammatory bowel disease by Walker, GJ, Harrison, JW, Heap, GA, Voskuil, MD, Andersen, V, Anderson, CA, Ananthakrishnan, AN, Barrett, JC, Beaugerie, L, Bewshea, CM, Cole, AT, Cummings, FR, Daly, MJ, Ellul, P, Fedorak, RN, Festen, EAM, Florin, TH, Gaya, DR, Halfvarson, J, Hart, AL, Heerasing, NM, Hendy, P, Irving, PM, Jones, SE, Koskela, J